Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for information and advice about coronavirus (COVID-19), including information about the COVID-19 vaccine, go to the NHS website. You can also find guidance and support on the GOV.UK website.
Link

Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy?
NHS England is not responsible for content on external websites.
Summary
This nurse-led study identified that female sexual morbidity after pelvic radiotherapy is not an addressed aspect of routine follow-up and cancer survivorship. The author recommends that development in both individual practice and service provision would improve the identification and management of treatment-induced female sexual difficulties. They report that addressing these factors, will provide better outcomes for female cancer survivors and give them better experiences.